Last update 07 Jul 2026

SYS6055

Overview

Basic Info

Drug Type
in vivo CAR-T therapy
Synonyms
SYS6055
Target
CD19
Action
inhibitors, modulators
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Aggressive B-Cell Non-Hodgkin LymphomaB-Cell Lymphoma
Inactive Indication-
Originator Organization
Beijing Kangchuanglian Biopharmaceutical Technology Research
Active Organization
Beijing Kangchuanglian Biopharmaceutical Technology Research
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SYS6055
NCT07493174
/ Not yet recruitingPhase 1IIT
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies
NCT07476066
/ Not yet recruitingPhase 1/2
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma
100 Clinical Results associated with SYS6055
Login to view more data
100 Translational Medicine associated with SYS6055
Login to view more data
100 Patents (Medical) associated with SYS6055
Login to view more data
100 Deals associated with SYS6055
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Aggressive B-Cell Non-Hodgkin LymphomaPhase 2
China
Beijing Kangchuanglian Biopharmaceutical Technology Research
07 Apr 2026
B-Cell LymphomaPhase 2-
Beijing Kangchuanglian Biopharmaceutical Technology Research
15 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free